> SIFI RECEIVES FAVORABLE FEEDBACK FROM THE US FDA ON AKANTIOR® FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS
 
Per le attività relative a Press & Communication prego contattare: CITYnet communication Rome, ITALY press@sifigroup.com Visita i nostri social channel!
Follow Us!